Longeveron (NASDAQ:LGVN) stock is up on Monday alongside a couple of pieces of news from the clinical-stage biotechnology company. First off, investors will note that there’s insider buying they ...

Explore Longeveron stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LGVN. EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In July 2024 – Where ...

LGVN has made substantial progress with its signature treatment, Lomecel-B, in treating both HLHS and Alzheimer's Disease and we suggest investors take a look at this stock before more good news ...

LGVN has made substantial progress with its signature treatment, Lomecel-B, in treating both HLHS and Alzheimer's Disease and we suggest investors take a look at this stock before more good news ...

Longeveron (NASDAQ:LGVN – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a note issued to investors on Friday,Benzinga reports. They currently have ...

Roth MKM analyst Boobalan Pachaiyappan reiterated a Buy rating on Longeveron (LGVN – Research Report) today and set a price target of $10.00.

LONGEVERON ($LGVN) is expected to release its quarterly earnings data on Friday, February 28th after market close, per Finnhub. Analysts are expecting revenue of ...

MIAMI, March 05, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic ...

Good day, and welcome to the Longeveron 2024 and Full Year Financial Results Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the ...